Literature DB >> 11207390

Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan.

Y Izumi1, H Morino, M Oda, H Maruyama, F Udaka, M Kameyama, S Nakamura, H Kawakami.   

Abstract

Dinucleotide repeat polymorphism has been observed in the promoter of the alpha-synuclein (alpha-SYN)/NAC precursor protein (NACP) gene. Alpha-SYN/NACP allele 3 (described by Xia et al. (Ann. Neurol., 40 (1996) 207), equivalent to allele 1 described by Krüger et al. (Ann. Neurol. 45 (1999) 611) is reported to be significantly more frequent among patients with sporadic Parkinson's disease (sPD) than controls. In this study, we genotyped the same alpha-SYN/NACP polymorphism in Japanese sPD patients and healthy controls, but found that any aliele showed no significant difference between the two groups.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207390     DOI: 10.1016/s0304-3940(01)01557-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  15 in total

Review 1.  Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.

Authors:  Subhrangshu Guhathakurta; Eugene Bok; Baggio A Evangelista; Yoon-Seong Kim
Journal:  Prog Neurobiol       Date:  2017-04-23       Impact factor: 11.685

2.  The PD-associated alpha-synuclein promoter Rep1 allele 2 shows diminished frequency in restless legs syndrome.

Authors:  Suna Lahut; David Vadasz; Candan Depboylu; Vincent Ries; Martina Krenzer; Karin Stiasny-Kolster; A Nazli Basak; Wolfgang H Oertel; Georg Auburger
Journal:  Neurogenetics       Date:  2014-05-27       Impact factor: 2.660

Review 3.  Genetic variability in SNCA and Parkinson's disease.

Authors:  Lasse Pihlstrøm; Mathias Toft
Journal:  Neurogenetics       Date:  2011-07-29       Impact factor: 2.660

4.  A cytosine-thymine (CT)-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression.

Authors:  Michael W Lutz; Robert Saul; Colton Linnertz; Omolara-Chinue Glenn; Allen D Roses; Ornit Chiba-Falek
Journal:  Alzheimers Dement       Date:  2015-06-13       Impact factor: 21.566

5.  Variant in the 3' region of SNCA associated with Parkinson's disease and serum α-synuclein levels.

Authors:  Yacen Hu; Beisha Tang; Jifeng Guo; Xintian Wu; Qiying Sun; Changhe Shi; Liang Hu; Chunyu Wang; Lei Wang; Liming Tan; Lu Shen; Xinxiang Yan; Hainan Zhang
Journal:  J Neurol       Date:  2011-08-19       Impact factor: 4.849

6.  alpha-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease.

Authors:  C K Wang; C M Chen; C Y Chang; K H Chang; I C Chen; M L Li; G-J Lee-Chen; Y R Wu
Journal:  J Neural Transm (Vienna)       Date:  2006-04-11       Impact factor: 3.575

7.  Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.

Authors:  Ornit Chiba-Falek; Jeffrey A Kowalak; Mark E Smulson; Robert L Nussbaum
Journal:  Am J Hum Genet       Date:  2005-01-25       Impact factor: 11.025

8.  Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene.

Authors:  Ornit Chiba-Falek; Jeffrey W Touchman; Robert L Nussbaum
Journal:  Hum Genet       Date:  2003-08-16       Impact factor: 4.132

Review 9.  Genetic susceptibility in Parkinson's disease.

Authors:  Jose Miguel Bras; Andrew Singleton
Journal:  Biochim Biophys Acta       Date:  2008-11-20

10.  Whole-genome conditional two-locus analysis identifies novel candidate genes for late-onset Parkinson's disease.

Authors:  A González-Pérez; J Gayán; J Marín; J J Galán; M E Sáez; L M Real; C Antúnez; A Ruiz
Journal:  Neurogenetics       Date:  2009-01-21       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.